Murae Organisor Limited (BOM:542724)
0.2400
0.00 (0.00%)
At close: Jan 19, 2026
Murae Organisor Revenue
Murae Organisor had revenue of 39.87M INR in the quarter ending June 30, 2025, with 505.04% growth. This brings the company's revenue in the last twelve months to 8.59B, up 26,712.09% year-over-year. In the fiscal year ending March 31, 2025, Murae Organisor had annual revenue of 8.55B with 26,594.83% growth.
Revenue (ttm)
8.59B
Revenue Growth
+26,712.09%
P/S Ratio
0.05
Revenue / Employee
n/a
Employees
n/a
Market Cap
427.56M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 8.55B | 8.52B | 26,594.83% |
| Mar 31, 2024 | 32.02M | -117.45M | -78.58% |
| Mar 31, 2023 | 149.47M | -60.89M | -28.94% |
| Mar 31, 2022 | 210.36M | -200.48M | -48.80% |
| Mar 31, 2021 | 410.84M | -140.25M | -25.45% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Welcure Drugs and Pharmaceuticals | 3.66B |
| Walpar Nutritions | 757.46M |
| JFL Life Sciences | 744.78M |
| Sandu Pharmaceuticals | 667.62M |
| Shelter Pharma | 598.96M |
| Gujarat Terce Laboratories | 501.95M |
| Panjon | 463.51M |
| Biofil Chemicals and Pharmaceuticals | 455.49M |
Murae Organisor News
- 8 months ago - Murae Organisor secures agri commodity orders worth up to Rs 297 crore - Business Upturn